A 52 Weeks, Open-Label, Multicenter Study Evaluating The Efficacy And Safety Of Gabapentin As Adjunctive Therapy In Pediatric Patients Who Have Completed The 12 Weeks Treatment In Study A9451162 (NCT00603473)
A 52 Weeks, Open-Label, Multicenter Study Evaluating The Efficacy And Safety Of Gabapentin As Adjunctive Therapy In Pediatric Patients Who Have Completed The 12 Weeks Treatment In Study A9451162 (NCT00603473)
Examine the safety and efficacy of gabapentin as adjunctive therapy in Japanese pediatric patients with partial seizures
Inclusion Criteria:
Exclusion Criteria:
Obu-shi,Morioka-machi, Aichi-ken, Japan
Jonan-ku, Fukuoka, Japan
Zentsuuji, Kagawa-ken, Japan
Izumi-shi, Osaka, Japan
Miyakojima-ku, Osaka, Japan
Setagaya-ku, Tokyo, Japan
Shinjuku-ku, Tokyo, Japan